Literature DB >> 28101360

Successful treatment of anti-NMDA receptor encephalitis with a prompt ovarian tumour removal and prolonged course of plasmapheresis: A case report.

Elzbieta Rypulak1, Michal Borys1, Pawel Piwowarczyk1, Magdalena Fijalkowska1, Beata Potrec1, Justyna Sysiak1, Janusz Spustek2, Alicja Bartkowska-Sniatkowska3, Jan Kotarski4, Waldemar A Turski5, Konrad Rejdak6, Miroslaw Czuczwar1.   

Abstract

Anti-N-methyl-d-aspartate-receptor (NMDAR) encephalitis is an uncommon autoimmune disorder with a wide spectrum of neuropsychiatric symptoms. There is a great requirement to emphasize the importance of a multidisciplinary team approach in the process of diagnosis and treatment of the potentially fatal condition, including psychiatrists, neurologists, gynaecologists and intensivists. Physicians must be aware that psychiatric and neurological disorders, which are typical features for NMDAR encephalitis in young women with ovarian tumours, may progress into status epilepticus and respiratory insufficiency. This disease can only be successfully treated with prompt surgical intervention and an early implementation of a wide array of immunosuppressive therapies. Optimal timing of initiation of therapeutic plasma exchange, as well as duration of treatment necessary to achieve desirable outcomes in patients with NMDAR remains unknown. The present case report aims to raise awareness about the importance of early implementation of this potentially life-saving therapy and continuing the treatment courses until full subsidence of symptoms.

Entities:  

Keywords:  EEG abnormalities; anti-NMDA receptor antibodies; autoimmune encephalitis; status epilepticus; therapeutic plasma exchange

Year:  2016        PMID: 28101360      PMCID: PMC5228193          DOI: 10.3892/mco.2016.1054

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  25 in total

1.  Rituximab used successfully in the treatment of anti-NMDA receptor encephalitis.

Authors:  Ryotaro Ikeguchi; Koichi Shibuya; Shigeo Akiyama; Shuji Hino; Hiromasa Kubo; Takahiro Takeda; Noriyuki Shibata; Kenji Yamamoto
Journal:  Intern Med       Date:  2012-06-15       Impact factor: 1.271

2.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

3.  Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.

Authors:  Allen D DeSena; Daniel K Noland; Karen Matevosyan; Kathryn King; Lauren Phillips; Sara S Qureshi; Benjamin M Greenberg; Donna Graves
Journal:  J Clin Apher       Date:  2015-02-09       Impact factor: 2.821

4.  [Safety of plasma exchange therapy in patients with anti-NMDA receptor encephalitis].

Authors:  Yan Zhang; Daiquan Gao; Hong Ye; Yingying Su
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2015-05-19

5.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 6.  Adjunct therapeutic plasma exchange for anti-N-methyl-D-aspartate receptor antibody encephalitis: a case report and review of literature.

Authors:  M Kamran Mirza; Jennifer Pogoriler; Kristen Paral; Vijayalakshmi Ananthanarayanan; Saptarshi Mandal; Abdul Mazin; Beverly Baron; Elie Richa
Journal:  J Clin Apher       Date:  2011-10-29       Impact factor: 2.821

Review 7.  [Fast and spectacular clinical response to plasmapheresis in a paediatric case of anti-NMDA encephalitis].

Authors:  N Nunez-Enamorado; A Camacho-Salas; S Belda-Hofheinz; C Cordero-Castro; R Simon-De Las Heras; R Saiz-Diaz; F J Martinez-Sarries; B Martinez-Menendez; F Graus
Journal:  Rev Neurol       Date:  2012-04-01       Impact factor: 0.870

8.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

9.  N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Authors:  Sarosh R Irani; Katarzyna Bera; Patrick Waters; Luigi Zuliani; Susan Maxwell; Michael S Zandi; Manuel A Friese; Ian Galea; Dimitri M Kullmann; David Beeson; Bethan Lang; Christian G Bien; Angela Vincent
Journal:  Brain       Date:  2010-06       Impact factor: 13.501

10.  Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal.

Authors:  T Iizuka; F Sakai; T Ide; T Monzen; S Yoshii; M Iigaya; K Suzuki; D R Lynch; N Suzuki; T Hata; J Dalmau
Journal:  Neurology       Date:  2007-09-26       Impact factor: 9.910

View more
  4 in total

1.  Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yanbo He; Yingying Su
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

2.  Efficacy of Therapeutic Plasma Exchange in Patients with Severe Refractory Anti-NMDA Receptor Encephalitis.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yingying Su
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 3.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

Review 4.  Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.

Authors:  Laurent M Willems; Sebastian Bauer; Kolja Jahnke; Martin Voss; Felix Rosenow; Adam Strzelczyk
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.